Rate My Professor Kathryn Hally

Hally's research centers on translational cardiovascular medicine, innate immunology, platelet biology, and flow cytometry. She employs full-spectrum flow cytometry to analyze circulating immune cell phenotypes for biomarker discovery, particularly developing inflammation-based risk scores to predict myocardial repair after infarction. This enables personalized therapy and rehabilitation for patients at risk of poor cardiac outcomes. Her investigations extend to the immunology of human disease in cardiovascular conditions, surgery, and surgical cancers, examining how acute immune responses shape long-term recovery. Key publications include "Revisiting platelets and toll-like receptors (TLRs): at the interface of vascular immunity and thrombosis" (2020, International Journal of Molecular Sciences), "Platelet Toll-like receptor (TLR) expression and TLR-mediated platelet activation in acute myocardial infarction" (2017, Thrombosis Research), "Linking neutrophil extracellular traps and platelet activation: a composite biomarker score for predicting outcomes after acute myocardial infarction" (2021, Thrombosis and Haemostasis), and "CPHEN-017: Comprehensive phenotyping of neutrophil extracellular traps (NETs) on peripheral human neutrophils" (2024, Cytometry Part A). Hally has secured Health Research Council funding for projects predicting surgical recovery via immune responses and supervises postgraduate students in immunology and cytometry techniques.